Percutaneous site-specific pharmacomechanical thrombolysis- thrombectomy system for bilateral acute limb ischemia

J Invasive Cardiol. 2011 Feb;23(2):81-3.

Abstract

Acute limb ischemia (ALI) remains a life-threatening condition. Studies with catheter-directed thrombolysis and percutaneous mechanical thrombectomy systems show modest improvements in mortality compared to surgery but with pitfalls of major bleeding, distal embolization, recurrent thrombosis, prolonged thrombolytic infusion and increased overall cost. We present a unique and therapeutically challenging case of bilateral acute lower limb ischemia that was managed percutaneously in one setting by a novel technique using site-specific (isolated) pharmaco-mechanical thrombolysis-thrombectomy (IPMT) system.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Arterial Occlusive Diseases / drug therapy
  • Arterial Occlusive Diseases / surgery
  • Combined Modality Therapy
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Ischemia / drug therapy*
  • Ischemia / surgery*
  • Leg / blood supply*
  • Male
  • Middle Aged
  • Peripheral Vascular Diseases / drug therapy
  • Peripheral Vascular Diseases / surgery
  • Recombinant Proteins / therapeutic use
  • Thrombectomy / methods*
  • Thrombolytic Therapy / methods*
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Tissue Plasminogen Activator